{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:19:08Z","timestamp":1790983148906,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.7759\/cureus.111911","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:48:06Z","timestamp":1782931686000},"source":"Crossref","is-referenced-by-count":1,"title":["Donanemab Infusion and Recurrent Seizures in a Patient With Alzheimer\u2019s Disease and Epilepsy in the Absence of Amyloid-Related Imaging Abnormalities (ARIA)"],"prefix":"10.7759","author":[{"given":"Patricio S","family":"Espinosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Preisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15101101","article-title":"Therapeutic advances in targeting the amyloid-\u03b2 pathway for Alzheimer\u2019s disease","volume":"15","author":"Zhang B","year":"2025","unstructured":"Zhang B, Li Y, Li H, Shen X, Zhu Z. Therapeutic advances in targeting the amyloid-\u03b2 pathway for Alzheimer\u2019s disease. Brain Sci. 2025, 15:10.3390\/brainsci15101101","journal-title":"Brain Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel KA","year":"2013","unstructured":"Vossel KA, Beagle AJ, Rabinovici GD, et al.. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013, 70:1158-66. 10.1001\/jamaneurol.2013.136","journal-title":"JAMA Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.46.3.727","article-title":"Dementia and adult-onset unprovoked seizures","volume":"46","author":"Hesdorffer DC","year":"1996","unstructured":"Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology. 1996, 46:727-30. 10.1212\/wnl.46.3.727","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's disease","volume":"384","author":"Mintun MA","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, et al.. Donanemab in early Alzheimer's disease. N Engl J Med. 2021, 384:1691-704. 10.1056\/NEJMoa2100708","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims JR","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, et al.. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023, 330:512-27. 10.1001\/jama.2023.13239","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop JJ","year":"2009","unstructured":"Palop JJ, Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol. 2009, 66:435-40. 10.1001\/archneurol.2009.15","journal-title":"Arch Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.04.004","article-title":"The role of inflammation in epileptogenesis","volume":"69","author":"Vezzani A","year":"2013","unstructured":"Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology. 2013, 69:16-24. 10.1016\/j.neuropharm.2012.04.004","journal-title":"Neuropharmacology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2014.10.003","article-title":"Blood-brain barrier dysfunction, seizures and epilepsy","volume":"38","author":"van Vliet EA","year":"2015","unstructured":"van Vliet EA, Aronica E, Gorter JA. Blood-brain barrier dysfunction, seizures and epilepsy. Semin Cell Dev Biol. 2015, 38:26-34. 10.1016\/j.semcdb.2014.10.003","journal-title":"Semin Cell Dev Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/407395-donanemab-infusion-and-recurrent-seizures-in-a-patient-with-alzheimers-disease-and-epilepsy-in-the-absence-of-amyloid-related-imaging-abnormalities-aria","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:48:06Z","timestamp":1782931686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/407395-donanemab-infusion-and-recurrent-seizures-in-a-patient-with-alzheimers-disease-and-epilepsy-in-the-absence-of-amyloid-related-imaging-abnormalities-aria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.111911","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}